Drug Shortage Report for AA-TELMISARTAN-AMLODIPINE

Last updated on 2022-06-10 History
Report ID 155482
Drug Identification Number 02473488
Brand name AA-TELMISARTAN-AMLODIPINE
Common or Proper name AA-TELMISARTAN-AMILODIPINE
Company Name AA PHARMA INC
Market Status MARKETED
Active Ingredient(s) AMLODIPINE TELMISARTAN
Strength(s) 5MG 80MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100BTL
ATC code C09DB
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2022-02-23
Actual start date
Estimated end date 2022-12-05
Actual end date
Shortage status Actual shortage
Updated date 2022-06-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1165 CREDITSTONE ROAD
VAUGHAN, ONTARIO
CANADA L4K 4N7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2022-06-10 French Compare
v4 2022-06-10 English Compare
v3 2022-02-24 English Compare
v2 2022-02-23 French Compare
v1 2022-02-23 English Compare

Showing 1 to 5 of 5